Medicare Enrolled
Dr. Paul Sutej, MD
Rheumatology · Atlanta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sutej from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sutej?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sutej
Dr. Paul Sutej is a rheumatology specialist in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sutej performed 166,496 Medicare services across 2,663 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sutej received a total of $236,409 from 47 pharmaceutical and/or device companies across 969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sutej is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in GA
$236,409 industry payments
Medicare Practice Summary
Medicare Utilization ↗166,496
Medicare services
Top 7% in GA for rheumatology
2,663
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~8,325 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
56,680 | $10 | $50 |
| Tocilizumab injection (Actemra) | 43,720 | $5 | $13 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
20,800 | $4 | $20 |
| Denosumab injection (Prolia/Xgeva) | 12,720 | $18 | $32 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
11,625 | $34 | $100 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
8,976 | $26 | $110 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
7,657 | $63 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
555 | $95 | $250 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
533 | $52 | $130 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
462 | $65 | $175 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
400 | $106 | $500 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
358 | $11 | $30 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
330 | $10 | $30 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
276 | $5 | $18 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
261 | $8 | $25 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
228 | $23 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
149 | $124 | $320 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
135 | $6 | $30 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
117 | $12 | $35 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
98 | $4 | $20 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
92 | $3 | $10 |
| Injection, methylprednisolone acetate, 40 mg | 87 | $6 | $19 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
80 | $58 | $230 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
39 | $4 | $10 |
| Tuberculosis blood test (gamma interferon) A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels. |
31 | $61 | $150 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
26 | $11 | $30 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
20 | $39 | $100 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
16 | $4 | $15 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
13 | $13 | $45 |
| Rheumatoid factor level | 12 | $6 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
47.0% high complexity
51.7% medium
1.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$236,409
Total received (2018-2024)
Avg $33,773/year across 7 years
Top 4% in GA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
969
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$202,428 (85.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$25,086 (10.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,896 (3.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,071
2023
$9,819
2022
$10,730
2021
$19,307
2020
$22,906
2019
$63,180
2018
$101,397
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$7,106
ABBVIE INC.
$422
UCB, Inc.
$271
Amgen Inc.
$236
GlaxoSmithKline, LLC.
$203
ANI Pharmaceuticals, Inc.
$193
E.R. Squibb & Sons, L.L.C.
$133
Janssen Biotech, Inc.
$82
Octapharma USA, Inc.
$74
GENZYME CORPORATION
$49
Aurinia Pharma U.S., Inc.
$48
Organon Llc
$41
Kiniksa Pharmaceuticals International, plc
$38
PFIZER INC.
$33
Mallinckrodt Hospital Products Inc.
$33
Teva Pharmaceuticals USA, Inc.
$24
AstraZeneca Pharmaceuticals LP
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Fresenius Kabi USA, LLC
$21
SOBI, INC
$19
Top 3 companies account for 86.0% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$53,740
Novartis Pharmaceuticals Corporation
$53,613
Celgene Corporation
$30,193
Regeneron Healthcare Solutions, Inc.
$27,752
GENZYME CORPORATION
$21,445
AbbVie, Inc.
$11,251
Amgen Inc.
$9,084
Janssen Biotech, Inc.
$7,720
AbbVie Inc.
$6,452
UCB, Inc.
$6,004
Gilead Sciences, Inc.
$1,684
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,337
E.R. Squibb & Sons, L.L.C.
$1,051
ABBVIE INC.
$970
GlaxoSmithKline, LLC.
$602
Horizon Therapeutics plc
$539
PFIZER INC.
$357
SANOFI-AVENTIS U.S. LLC
$346
Genentech USA, Inc.
$345
ANI Pharmaceuticals, Inc.
$193
Octapharma USA, Inc.
$172
MEDEXUS PHARMA, INC.
$167
Mallinckrodt Hospital Products Inc.
$150
Horizon Pharma plc
$150
Mallinckrodt Enterprises LLC
$104
FIDIA PHARMA USA INC.
$84
Mallinckrodt LLC
$83
Merck Sharp & Dohme Corporation
$80
Organon LLC
$76
Exeltis, USA Inc.
$72
Teva Pharmaceuticals USA, Inc.
$68
Aurinia Pharma U.S., Inc.
$68
Radius Health, Inc.
$58
AstraZeneca Pharmaceuticals LP
$50
Actelion Pharmaceuticals US, Inc.
$46
Organon Llc
$41
Sobi, Inc
$41
Kiniksa Pharmaceuticals International, plc
$38
WishBone Medical Inc.
$34
Flexion Therapeutics, Inc.
$33
Fresenius Kabi USA, LLC
$21
Pacira Therapeutics, Inc.
$19
SOBI, INC
$19
TerSera Therapeutics LLC
$18
Ferring Pharmaceuticals Inc.
$15
West-Ward Pharmaceuticals
$14
Zyla Life Sciences
$13
Top 3 companies account for 58.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · FORTEO · HADLIMA · HUMIRA · HYALGAN · Humira · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · ORENCIA · Otezla · PRIALT · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · TALTZ · TAVNEOS · TREMFYA · Truxima · Tyenne · Tymlos · UPTRAVI · Veklury · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for rheumatology in GA.
Geographic Context
Rheumatologists within 10 mi
88
Per 100K population
8.2
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sutej is a mixed practice specialist, with above-average Medicare volume (top 7% in GA), with speaking/promotional industry engagement in the top 4% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sutej experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Sutej performed 56,680 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sutej receive payments from pharmaceutical companies?
Yes. Dr. Sutej received a total of $236,409 from 47 companies across 969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sutej's costs compare to other rheumatologists in Atlanta?
Dr. Sutej's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sutej) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Atlanta
Browse rheumatologists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in GA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in GA
Which GA rheumatologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology